An industry for healthy lives

Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region.

Roadmap on the future of vaccine research in the EU

As Europe’s population faces increasing challenges from ageing and emerging health threats such as healthcare associated infections, high chronic disease incidence, and low levels of prevention uptake and awareness, research advancements are needed to allow the design of new generation vaccines potentially more efficacious and capable of targeting unmet medical needs.

Vaccines Europe is working on the development of a roadmap on the future of vaccine research and development in the EU for both prophylactic and therapeutic targets. The process starts from the identification of key gaps and needs across the academic, industry, SME, and the policy-making environment. The roadmap is looking into vaccine research, development, production, delivery and implementation aspects where innovation is necessary to deliver new and better vaccines.